From Hitachi Medical Systems America Inc.;
the AIRIS II, an entry in the diagnostic category of open MR systems, was designed by Hitachi Medical Systems America Inc. (Twinsburg, OH, USA) and Hitachi Medical Corp. (Tokyo) and is manufactured by the Tokyo branch. A 0.3 T field-strength magnet and phased array coils deliver high image quality without the need for a tunnel-type high-field system, thereby significantly improving patient comfort not only for claustrophobic patients.

Short name: PLLGd-DTPA, generic name: (Gd-DTPA)n-polylysine, chemical compound: Gd-DTPA poly(L-lysine-Gd-diethylenetriamine-N,N,N',N'',N''-pentaacetic acid), central moiety: Gd2+, relaxivity: r1=13.1, B0=0.23T
A polymeric MRI contrast agent under development (preclin., Bayer Schering Pharma AG, Berlin, Germany) with advantages in both MRA and in the differential diagnosis of tumors, particularly in perfusion studies of the myocardium and potential in MR lung perfusion. Dozens of the relatively small molecule Gd-DTPA is bound covalently to polylysine, a large molecular weight backbone. The stable, highly water-soluble agent does not diffuse through the endothelium of the vascular system; it is subject to renal elimination.

[This entry is marked for removal.]

Hitachi Medical Systems America, Inc. (HMSA), was a major provider of magnetic resonance imaging systems in the United States. Hitachi had more than 2300 installed permanent magnet MR imaging systems worldwide. As a full-line supplier of medical imaging equipment in Japan, Hitachi Medical Corporation (HMC) founded HMSA to provide a direct link to the U.S. marketplace. Altaire™ , the open MR system from Hitachi, extends the family of open MRI products.

In December 2019 Japan's Fujifilm announced the acquisition of Hitachi's diagnostic imaging business for 179 billion yen ($1.63 billion). This includes Hitachi’s CT, MRI, X-ray, and ultrasound imaging operations, also its electronic health record business. Fujifilm expects the deal to close in July 2020 subject to regulatory clearances.

MRI Scanners:

0.3T to 0.7T:
1.5T:

ISOL Technology participated in the pioneering the Korea's MRI development since the early 1980's. In spite of the rapidly changing business environment, and severe competition in the overall medical market, ISOL Technology has grown steadily each year and has established itself as a major provider of Magnetic Resonance(MR) Imaging Systems in Korea.
ISOL Technology also has the largest market share of the domestic bone densitometry equipment sales and is currently in the early stages of development of the 61 channel MCG (Magnetocardiography) system with the R and D funds from the Korean Ministry of Commerce, Industry and Energy.

MRI Scanners:

0.35T to 0.5T:
1.5T:
3T:

From Philips Medical Systems;
Philips continues to expand the frontiers of utra high field MRI with the introduction of the new Intera Achieva 3.0T™. Its powerful future-safe platform shares all the advantages of the Achieva family and covers applications throughout the whole body.